Core Viewpoint - MindBio Therapeutics Corp. is raising up to $650,000 through a non-brokered private placement to enhance its drug and alcohol intoxication detection technology for the mining industry [1][3]. Group 1: Offering Details - The Company will offer up to 1,083,333 units at a price of $0.60 per unit, aiming for gross proceeds of up to $650,000 [2]. - Each unit consists of one common share and one share purchase warrant, with the warrant allowing the purchase of an additional share at $0.80 for 36 months, subject to accelerated expiry conditions [2]. - The Offering is subject to final board and regulatory approvals, and all securities will have a four-month-and-one-day resale restriction [4]. Group 2: Use of Proceeds - The net proceeds from the Offering will be used to accelerate the development and deployment of proprietary hardware and edge technology for remote use of the intoxication detection solution in mining [3]. - The funds will also support the recruitment of specialized personnel and general working capital purposes [3]. Group 3: Company Overview - MindBio is a biotechnology company focused on commercializing AI prediction technologies for drug and alcohol intoxication detection through voice analysis, utilizing over 50 million data points for accuracy [6]. - The Company is in the process of expanding its prediction tool to cover other types of intoxication for both consumer and enterprise applications [6].